semaglutide health risks Who Should Consider GLP-1? Semaglutide GLP-1 is generally recommended for individuals with type 2 diabetes who have not achieved adequate blood sugar control with other medications such as metformin, or for Ozempic and similar weight loss

(Photo illustration by Scott Olson/Getty Images) The Trump administration this month scrapped a Biden-era proposal that would have required state Medicaid programs and allowed federal Medicare to pay for some GLP-1s for obesity treatment

Another key question is whether beneficial effects of these drugs extend to all patients with alcohol use disorders and other addictions, a significant minority of whom are underweight. Join our commenting forum Join thought-provoking conversations, follow other Independent readers and see their replies Comments

We care about your well being and happiness

Clinical studies published through the National Library of Medicine show that both oral and injectable semaglutide lead to weight loss and metabolic improvements over approximately 26 weeks